EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Effect of Potassium‐Competitive Acid Blockers on Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

Minyoul Baik iD, Jimin Jeon, Joonsang Yoo, Jinkwon Kim iD

Journal of Gastroenterology and Hepatology · 2025-07 · 40 (7) · 1686-1694

DOI: 10.1111/jgh.16989 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 27.04.2025. Verfasst von Minyoul Baik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si, Gyeonggi-do, South Korea. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Proton Pump Inhibitors, Gastrointestinal Hemorrhage, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Daewoong Pharmaceutical Company, National Research Foundation of Korea grant funded by the Korea government (MSIT), Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Proton pump inhibitors (PPIs) are the drug of choice to prevent upper gastrointestinal (UGI) bleeding in patients receiving dual antiplatelet therapy (DAPT); however, unmet needs remain. Potassium‐competitive acid blockers (P‐CABs) are novel acid‐suppressive drugs that have emerged as potential alternatives. We evaluated the effectiveness of P‐CAB in reducing the risk of UGI bleeding in patients receiving DAPT after percutaneous coronary intervention (PCI).

Methods

This retrospective cohort study included patients with PCI on DAPT between January 2019 and January 2023 using the Korean nationwide health claims database. The primary outcome was admission for UGI bleeding within 6 months of PCI. A multivariate Cox regression model was used to evaluate UGI bleeding risk based on PPIs and P‐CAB use.

Results

Of the 210 447 patients who underwent PCI on DAPT (mean age, 65.5 years; 74.7% men), 4.6% and 47.5% patients were prescribed P‐CABs and PPIs, respectively. Overall, 0.3% of patients experienced UGI bleeding within 6 months of PCI. P‐CAB users had a reduced risk of UGI bleeding (adjusted hazard ratio, 0.59; 95% confidence interval, 0.38–0.92; p = 0.019) compared with patients not receiving P‐CAB or PPI. No significant difference was observed between the P‐CAB and PPI users ( p > 0.05).

Conclusions

Among Korean patients undergoing PCI with DAPT, P‐CABs reduced UGI bleeding comparably to PPIs. These findings suggest that P‐CABs are potential alternatives to PPIs for preventing UGI bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionProton Pump InhibitorsGastrointestinal HemorrhagePlatelet Aggregation InhibitorsDual Anti-Platelet TherapyHumansMaleFemaleAgedRetrospective StudiesMiddle AgedRepublic of KoreaCohort Studies

Stichwörter der Autor:innen

dual antiplatelet therapypercutaneous coronary interventionpotassium‐competitive acid blockerproton pump inhibitorupper gastrointestinal bleeding

Substanzen

Proton Pump InhibitorsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si, Gyeonggi-do, South Korea.

ORCID-Profile: Minyoul Baik, Jinkwon Kim

Förderung

  • Daewoong Pharmaceutical Company
  • National Research Foundation of Korea grant funded by the Korea government (MSIT)
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Baik, M., Jeon, J., Yoo, J., & Kim, J. (2025). Effect of Potassium‐Competitive Acid Blockers on Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. Journal of Gastroenterology and Hepatology, 40(7), 1686-1694. https://doi.org/10.1111/jgh.16989

Vancouver

Baik M, Jeon J, Yoo J, Kim J. Effect of Potassium‐Competitive Acid Blockers on Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. Journal of Gastroenterology and Hepatology. 2025;40(7):1686-1694. doi:10.1111/jgh.16989

BibTeX
@article{Baik2025,
  author = {Baik, Minyoul and Jeon, Jimin and Yoo, Joonsang and Kim, Jinkwon},
  title = {Effect of Potassium‐Competitive Acid Blockers on Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  volume = {40},
  number = {7},
  pages = {1686--1694},
  doi = {10.1111/jgh.16989}
}
Kostenlos starten →